Please assess the completion status of the following clinical trial:

Trial Title: Vytorin Treating Uncontrolled Lipids (VyTUL) Study (0653A-122)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Greater than 18 years of age~* Treated for at least the last 3 months with a daily dose of atorvastatin 40 mg~* Existing coronary heart disease and cholesterol \> 4.0 mmol/l~Exclusion Criteria:~* Uncontrolled diabetes~* Elevated liver function tests~* Elevated creatine kinase (ck)~* Triglycerides (tg) \> 4.5 mmol/l~* Drug or alcohol dependency within 6 months prior to visit 1~* Woman receiving hormonal therapy who have not been maintained on a stable dose and regimen for at least 8 weeks and are willing to continue the same regimen for the duration of the study~* Woman of childbearing potential not using an acceptable method of birth control~* Women who are pregnant or breast feeding

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).